ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

ClinicalTrials.gov ID: NCT03325556

Public ClinicalTrials.gov record NCT03325556. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis

Study identification

NCT ID
NCT03325556
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
392 participants

Conditions and interventions

Interventions

  • Pimavanserin 20 mg Drug
  • Pimavanserin 34 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 26, 2017
Primary completion
Jul 30, 2019
Completion
Oct 29, 2019
Last update posted
Jun 20, 2021

2017 – 2019

United States locations

U.S. sites
27
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
ATP Clinical Research Inc. Costa Mesa California 92626
Neurology Center of North Orange County Fullerton California 92835
Visionary Investigators Network (Aventura Neurologic Associates) Aventura Florida 33180
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
Premier Clinical Research Institute, Inc. Miami Florida 33122
Visionary Investigators Network (First Choice Neurology Group) Miami Florida 33176
Novel Clinical Research Center, LLC Miami Florida 33186
Collier Neurologic Specialists LLC Naples Florida 34102
Bioclinica Research Orlando Florida 32806
Neurology Associates of Ormond Beach Ormond Beach Florida 32174
Quantum Laboratories Pompano Beach Florida 33064
Neuroscience Research Institute Winfield Illinois 60190
University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas 66160
Alzheimer Disease Center Quincy Massachusetts 02169
Clinical Research Professionals Chesterfield Missouri 63005
Millennium Psychiatric Associates, LLC; DBA Millennium Center for Clinical Research St Louis Missouri 63132
Neurology Center of Las Vegas Las Vegas Nevada 89128
Memory Enhancement Center of America, Inc. Eatontown New Jersey 07724
BioBehavioral Health Toms River New Jersey 08755
Neurological Associates of Albany, PC Albany New York 12208
Manhattan Behavioral Medicine, PLLC New York New York 10036
Richmond Behavioral Associates Staten Island New York 10312
Neuro-Behavioral Clinical Research, Inc. North Canton Ohio 44720
Thomas Jefferson University Philadelphia Pennsylvania 19107
Abington Neurological Associates Ltd. Willow Grove Pennsylvania 19090
University of Tennessee Medical Center Knoxville Tennessee 37920
University of Virginia Adult Neurology Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03325556, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03325556 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →